One hundred years after the 1918 pandemic, influenza remains a major cause of disease, killing between 290,000 – 650,000 people globally and afflicting millions of others each year. A universal influenza vaccine could protect against all influenza viruses – both seasonal and pandemic strains – saving countless lives.

Photo Credit: CDC Influenza Division

Shaping a Path Forward

The Global Funders Consortium for Universal Influenza Vaccine Development is a mechanism to bring together major funders of research and development of universal influenza vaccines along with key stakeholders to accelerate progress in the field through creating a common landscape, identifying critical gaps, and coordinating around a common vision.

Latest News & Updates

Seasonal Influenza Virus Infections Are Deadly

Seasonal influenza virus infections lead to an estimated 290,000 – 650,000 deaths each year worldwide.

Universal Vaccine Progress Has Been Slow

The development of universal influenza vaccines has been a public health goal for decades, progress has been slow.

Accelerated Progress To Prevent Pandemics

Progress can be accelerated through better coordination around a common vision. That’s where we come in.

Facilitating Collaborative Approaches

The Consortium will bring together the latest data and progress in the field of universal vaccine development to maximize the opportunities for impactful and efficient investments going forward.

Start typing and press Enter to search